U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H37NO4
Molecular Weight 499.6405
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CAREBASTINE

SMILES

CC(C)(C(O)=O)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=XGHOVGYJHWQGCC-UHFFFAOYSA-N
InChI=1S/C32H37NO4/c1-32(2,31(35)36)27-17-15-24(16-18-27)29(34)14-9-21-33-22-19-28(20-23-33)37-30(25-10-5-3-6-11-25)26-12-7-4-8-13-26/h3-8,10-13,15-18,28,30H,9,14,19-23H2,1-2H3,(H,35,36)

HIDE SMILES / InChI

Molecular Formula C32H37NO4
Molecular Weight 499.6405
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Carabestine is the active first-pass metabolite of Ebastine and acts as a histamine H1 receptor antagonist which has been investigated as a potential allergy medication. Ebastine is marketed under a number of brand names.

Originator

Curator's Comment: Carebastine was first mentioned by Vincent, Liminana, Meredith and Reid from Stobhill General Hospital, Glasgow https://www.ncbi.nlm.nih.gov/pubmed/2905150

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P35367
Gene ID: 3269.0
Gene Symbol: HRH1
Target Organism: Homo sapiens (Human)
9.7 nM [Ki]
Conditions
PubMed

PubMed

TitleDatePubMed
The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
1988 Nov
Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
2000
Patents

Sample Use Guides

In Phase III clinical trials patients were treated with a nasal spray containing Carebastine in a concentration of 2.5 mg/mL, and as an eye drop containing Carebastine at a concentration of 25 mg/mL.
Route of Administration: Other
In a dose–response study: CHO-H1R cells were incubated with Carebastine (1 nM – 1 μM) for 1 h. Effectiveness was assessed by measuring the accumulation of inositol phosphates.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:24:02 UTC 2023
Edited
by admin
on Fri Dec 15 16:24:02 UTC 2023
Record UNII
75DLN707DO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CAREBASTINE
INN  
INN  
Official Name English
carebastine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL67654
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
MESH
C058251
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
CAS
90729-42-3
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
NCI_THESAURUS
C77432
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
FDA UNII
75DLN707DO
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
PUBCHEM
65820
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
EPA CompTox
DTXSID60238246
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
EVMPD
SUB06623MIG
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
SMS_ID
100000084571
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
INN
5634
Created by admin on Fri Dec 15 16:24:02 UTC 2023 , Edited by admin on Fri Dec 15 16:24:02 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Produced as oxidation product with mediator.
Related Record Type Details
ACTIVE MOIETY